Your browser is no longer supported. Please, upgrade your browser.
Settings
DMTX Dimension Therapeutics, Inc. daily Stock Chart
DMTX [NASD]
Dimension Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.13 Insider Own- Shs Outstand24.17M Perf Week40.48%
Market Cap142.60M Forward P/E- EPS next Y-1.72 Insider Trans- Shs Float24.17M Perf Month391.67%
Income-53.20M PEG- EPS next Q-0.52 Inst Own71.50% Short Float0.99% Perf Quarter306.90%
Sales14.90M P/S9.57 EPS this Y55.40% Inst Trans-5.21% Short Ratio1.11 Perf Half Y247.06%
Book/sh1.44 P/B4.10 EPS next Y18.10% ROA-61.90% Target Price4.78 Perf Year-32.65%
Cash/sh1.97 P/C3.00 EPS next 5Y- ROE-98.70% 52W Range1.05 - 9.14 Perf YTD35.63%
Dividend- P/FCF- EPS past 5Y- ROI-73.80% 52W High-35.45% Beta-
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low461.90% ATR0.32
Employees74 Current Ratio3.30 Sales Q/Q83.30% Oper. Margin- RSI (14)90.96 Volatility4.67% 6.60%
OptionableNo Debt/Eq0.16 EPS Q/Q-1.30% Profit Margin- Rel Volume0.50 Prev Close5.85
ShortableYes LT Debt/Eq0.09 EarningsAug 10 Payout- Avg Volume216.07K Price5.90
Recom2.50 SMA2049.65% SMA50149.00% SMA200157.87% Volume108,903 Change0.85%
Sep-19-17Downgrade Citigroup Neutral → Sell
May-12-17Downgrade Citigroup Buy → Neutral
Jan-31-17Downgrade Cantor Fitzgerald Overweight → Neutral $32 → $3
Jun-03-16Initiated Cantor Fitzgerald Buy $32
Jun-02-16Initiated Jefferies Buy
Mar-30-16Downgrade Goldman Buy → Neutral
Feb-18-16Initiated Cantor Fitzgerald Buy $10
Dec-04-15Initiated Wells Fargo Outperform
Nov-16-15Initiated Goldman Buy
Nov-16-15Initiated Citigroup Buy
Nov-16-15Initiated Canaccord Genuity Buy $20
Nov-06-15Initiated ROTH Capital Buy $31
Nov-02-15Initiated Chardan Capital Markets Neutral $13
Sep-19-17 08:10AM  Today's Research Reports on Stocks to Watch: Dimension Therapeutics and Clovis Oncology ACCESSWIRE
08:00AM  Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a Superior Proposal GlobeNewswire
Sep-18-17 03:10PM  Dimension Confirms Receipt of Unsolicited Proposal from Ultragenyx GlobeNewswire +40.48%
01:18PM  UPDATED: Dimension Therapeutics shares surge 38% on Ultragenyx bid MarketWatch
09:35AM  Ultragenyx Makes Bid for Dimension Therapeutics - Biotech Movers TheStreet.com
08:35AM  Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 Per Share in Cash GlobeNewswire
Sep-05-17 06:00AM  OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors PR Newswire +10.79%
Aug-31-17 06:23PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Dimension Therapeutics, Inc. - DMTX PR Newswire +8.80%
06:07PM  ETFs with exposure to Dimension Therapeutics, Inc. : August 31, 2017 Capital Cube
03:20PM  INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Dimension Therapeutics, Inc. and Encourages Shareholders to Contact the Firm for Additional Information Business Wire
08:00AM  Dimension Therapeutics Commences Patient Dosing in Global, Multi-Center Phase 1/2 Clinical Trial of DTX301 in Ornithine Transcarbamylase (OTC) Deficiency GlobeNewswire
Aug-29-17 11:45AM  DIMENSION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dimension Therapeutics, Inc. PR Newswire
Aug-28-17 05:53PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Dimension Therapeutics, Inc. - DMTX ACCESSWIRE
Aug-25-17 05:26PM  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Dimension Therapeutics, Inc. Business Wire +162.50%
03:32PM  SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Dimension Therapeutics, Inc. and Encourages Investors to Contact the Firm for Additional Information Business Wire
03:30PM  DIMENSION THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
12:40PM  Rockville biotech buys Cambridge gene therapy firm for $86M American City Business Journals
11:49AM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
11:25AM  Cambridge gene therapy firm Dimension Therapeutics to be acquired American City Business Journals
09:43AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Dimension Therapeutics, Inc. to REGENXBIO Inc. is Fair to Shareholders Business Wire
08:00AM  REGENXBIO to Acquire Dimension Therapeutics GlobeNewswire
Aug-08-17 11:51PM  Dimension Therapeutics reports 2Q loss Associated Press -10.71%
08:00AM  Dimension Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Jul-24-17 08:00AM  Dimension Therapeutics Announces Management Change GlobeNewswire
Jul-13-17 09:00AM  Women In Bio Announces Mary Thistle Joins Enteromes Board of Directors GlobeNewswire
Jul-12-17 03:00AM  Enterome Appoints Mary Thistle to its Board of Directors PR Newswire +8.33%
Jun-28-17 11:25AM  Cambridge's Dimension slashes headcount after lead drug flops American City Business Journals -9.68%
Jun-27-17 08:00AM  Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities GlobeNewswire
Jun-22-17 03:38PM  ETFs with exposure to Dimension Therapeutics, Inc. : June 22, 2017 Capital Cube
Jun-05-17 02:12PM  ETFs with exposure to Dimension Therapeutics, Inc. : June 5, 2017 Capital Cube
Jun-02-17 10:14AM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-10-17 08:10AM  Dimension Therapeutics reports 1Q loss Associated Press
08:00AM  Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Apr-24-17 12:05PM  Dimension Therapeutics Announces Presentations at the Upcoming American Society for Gene and Cell Therapy (ASGCT) Annual Meeting GlobeNewswire
Apr-07-17 04:21PM  ETFs with exposure to Dimension Therapeutics, Inc. : April 7, 2017 Capital Cube
Mar-22-17 03:33PM  Edited Transcript of DMTX earnings conference call or presentation 9-Mar-17 1:30pm GMT Thomson Reuters StreetEvents
Mar-21-17 11:27AM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube -12.50%
11:27AM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar-14-17 02:43PM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Capital Cube
02:43PM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
01:04PM  DIMENSION THERAPEUTICS, INC. Financials
10:15AM  Can The Uptrend Continue for Dimension Therapeutics (DMTX)? Zacks
Mar-09-17 08:30AM  Dimension Therapeutics Inc Earnings and Business Update Call scheduled for 8:30 am ET today
07:47AM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:34AM  DIMENSION THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
07:30AM  Dimension Therapeutics Announces Full Year 2016 Financial Results and Recent Updates Across Rare and Metabolic Disease Portfolio and in HeLa Manufacturing GlobeNewswire
07:07AM  Q4 2016 Dimension Therapeutics Inc Earnings Release - Before Market Open
Mar-07-17 08:00AM  Dimension Therapeutics to Hold Full Year 2016 Financial Results and Recent Program Updates Conference Call GlobeNewswire
Feb-17-17 05:11PM  Lifshitz & Miller LLP Announces Investigation of BT Group plc, Celadon Group, Inc., Community Health Systems, Inc., Dimension Therapeutics, Inc., Home Capital Group Inc., Lifevantage Corporation, OvaScience, Inc. and Under Armour, Inc. PR Newswire
Feb-14-17 12:40PM  Newman Ferrara LLP Announces Corporate Governance Investigation of Dimension Therapeutics Inc. Business Wire
Feb-13-17 09:40AM  Cerner's EHR Platform to Enhance Health Care at San Juan NGO Zacks
Feb-07-17 08:00AM  Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors GlobeNewswire -13.16%
Feb-02-17 11:50AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dimension Therapeutics, Inc. Business Wire
Jan-31-17 12:59PM  Dimension Therapeutics downgraded by Cantor Fitzgerald -54.12%
08:26AM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events
08:00AM  Dimension Announces Interim Topline Results from Ongoing Phase 1/2 Clinical Program for DTX101, Dimensions Lead AAV Product Candidate in Development for Adult Patients with Moderate/Severe to Severe Hemophilia B GlobeNewswire
Jan-25-17 08:40AM  vTv Therapeutics (VTVT) in Focus: Stock Moves 6.7% Higher
Jan-20-17 04:32PM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-14-16 12:55AM  Is Dimension Therapeutics Inc (DMTX) Going to Burn These Hedge Funds? at Insider Monkey
Dec-13-16 08:00AM  Dimension Therapeutics Announces FDA Acceptance of Investigational New Drug Application for DTX301 to Treat OTC Deficiency GlobeNewswire
Dec-05-16 08:00AM  Dimension Therapeutics Announces Presentation at the 58th American Society of Hematology (ASH) Annual Meeting GlobeNewswire +9.52%
Nov-29-16 08:00AM  Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease Type Ia (GSDIa) GlobeNewswire
Nov-14-16 02:17PM  Heres What We Are Looking For From The Upcoming Dimension Therapeutics Inc (DMTX) Data at Insider Monkey
01:14PM  ETFs with exposure to Dimension Therapeutics, Inc. : November 14, 2016
Nov-11-16 11:14AM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 +26.37%
05:01AM  Dimension Therapeutics reports 3Q loss
Nov-10-16 08:10AM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements +8.33%
08:03AM  DIMENSION THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
08:00AM  Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2016 Financial Results GlobeNewswire
Nov-03-16 09:00AM  Dimension Therapeutics Announces Presentation at the Upcoming 58th American Society of Hematology (ASH) Annual Meeting GlobeNewswire -9.18%
Oct-18-16 08:00AM  Dimension Therapeutics Announces Presentations Highlighting Advances in AAV Manufacturing at the European Society of Gene and Cell Therapy (ESGCT) Congress GlobeNewswire +10.06%
Oct-11-16 08:00AM  Dimension Therapeutics Announces Presentations at the Upcoming European Society of Gene and Cell Therapy (ESGCT) Congress GlobeNewswire
Oct-04-16 08:00AM  Dimension Therapeutics Announces Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease Type Ia (GSDIa) GlobeNewswire
Aug-24-16 11:53AM  ETFs with exposure to Dimension Therapeutics, Inc. : August 24, 2016
08:00AM  Dimension Therapeutics Announces Participation in Two Upcoming Investor Conferences GlobeNewswire
Aug-15-16 01:44PM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-11-16 08:20AM  Dimension Therapeutics reports 2Q loss
08:17AM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:08AM  DIMENSION THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
08:00AM  Dimension Therapeutics Reports Recent Corporate Progress and Second Quarter 2016 Financial Results GlobeNewswire
Aug-02-16 08:00AM  Dimension Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference GlobeNewswire
Jul-20-16 09:35AM  This 'bold' IPO will say a lot about Wall Street, biotech and gene therapy (Video) at bizjournals.com +9.81%
Jul-08-16 12:06PM  These 5 Stocks Are Breaking Out
Jul-07-16 08:00AM  Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing PR Newswire
Jun-29-16 08:00AM  Dimension Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference GlobeNewswire
Jun-22-16 08:00AM  Dimension Therapeutics Announces Recombinant DNA Advisory Committees Unanimous Approval of Phase 1/2 Study Protocol for DTX301, Lead Inherited Metabolic Disease (IMD) Product Candidate to Treat OTC Deficiency GlobeNewswire
Jun-21-16 08:00AM  Dimension Therapeutics Opens New Facility in Woburn and Expands Management Team GlobeNewswire
Jun-14-16 08:13AM  Will Dimension Therapeutics (DMTX) Continue to Surge Higher? -5.18%
Jun-08-16 08:48AM  Increased Earnings Estimates Seen for Dimension Therapeutics (DMTX): Can It Move Higher?
08:06AM  Dimension Therapeutics (DMTX) Jumps: Stock Moves 6.7% Up
Jun-04-16 11:25AM  2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially at 24/7 Wall St.
Jun-01-16 01:41PM  Dimension Therapeutics, Inc. :DMTX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-31-16 08:00AM  Dimension Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire
May-27-16 08:00AM  Dimension Therapeutics Announces Presentations at the 8th European Conference on Rare Diseases & Orphan Products (ECRD) GlobeNewswire
May-25-16 06:44PM  The 3 Best Developmental Stage Biotech Stocks Surging Now
May-20-16 04:34PM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:08AM  7 Stocks Under $10 Making Big Moves Higher
May-19-16 08:00AM  Dimension Therapeutics Announces Presentations at the Upcoming 21st Congress of the European Hematology Association (EHA) GlobeNewswire
May-12-16 11:53AM  Dimension Therapeutics reports 1Q loss
09:02AM  DIMENSION THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Developing novel, liver-directed gene therapies for rare genetic disorders.